Ignite Creation Date:
2024-05-06 @ 1:13 PM
Last Modification Date:
2024-10-26 @ 1:11 PM
Study NCT ID:
NCT03967938
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2020-07-09
First Post:
2019-02-11
Brief Title:
Efficacy of Olaparib in Advanced Cancers Occurring in Patients With Germline Mutations or Somatic Tumor Mutations in Homologous Recombination Genes
Sponsor:
AZ-VUB
Organization:
AZ-VUB
Organization Data
Organization:
AZ-VUB
Class:
OTHER
Study ID:
Precision 2 - Olaparib
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AZ-VUB
Lead Sponsor Class:
OTHER
Responsible Party:
Dr Sofie Joris
Responsible Party Title:
Coordinator Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
AZ-VUB
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| AstraZeneca | INDUSTRY |
| Kom Op Tegen Kanker | OTHER |